Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Protease-mediated Peptide Bond Formation, Summaries of Biochemistry

Side-reactions during Protease-catalyzed Peptide Synthesis.

Typology: Summaries

2020/2021

Uploaded on 06/21/2021

amritay
amritay 🇺🇸

4.7

(14)

256 documents

1 / 4

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
THE
JOURNAL
OF
BIOLOGICAL
CHEMISTRY
Printed
m
U.S.A.
Val.
256,
No.
3,
Issue
of
February
10,
pp.
1301-1304,
1981
Protease-mediated Peptide Bond Formation
ON
SOME UNEXPECTED OUTCOMES DURING ENZYMATIC SYNTHESIS OF LEU-ENKEPHALIN*
(Received for publication, August 6, 1980)
Willi Kullmann
From the Max-Planck-Znstitut
fur
Biophysikalische Chemie,
0.3400
Gottingen, Am Fussberg. Federal Republic
of
Germany
In the course of a study in protease-controlled peptide
synthesis, several promising pathways to synthetic en-
kephalins had to be discarded or modified because they
failed to give the required products. Partial deprotec-
tion of peptide fragments prior to chain elongation
resulted in an enhanced susceptibility of scissile bonds
to proteolysis. The use of proteases, the specificity
of
which was not confined solely to the bond to be synthe-
sized, thus led to
a
priori
cleavage
of
pre-existing pep-
tide bonds. Subsequently, enzyme-mediated synthesis
of
new peptide bonds between initial reactants and
nascent degradation products furnished undesired,
of-
ten truncated peptides.
A
detailed characterization of the undesired products
gave information as to whetber or not the peptide
bonds were susceptible to proteolytic cleavage or ac-
cessible via enzymatic synthesis. In this way, the un-
expected outcome
of
protease catalysis led to working
predictions regarding enzyme-mediated peptide bond
formation, and thus, finally contributed to the success-
ful synthesis of the target peptides.
Peptide bond formation on a preparative scale by the
agency of proteases has become a rapidly developing field
(1-
10).
In this approach, the enzymatic specificity suppresses the
formation of undesired side-products often found in the course
of conventional synthesis. In particular, it provides for an
outstanding way of maintaining chiral integrity because of the
stereoselectivity of the proteases. Furthermore, since the
products are often largely insoluble in the reaction media, this
method facilitates the purification procedure.
Despite these promising features, the enzymatic procedure
has not yet reached general applicability. Much of this draw-
back is due to the specificity, which is often not sharp enough
to permit predictions whether and to what extent the desired
compounds are going to be formed. On the other hand, it
cannot be reliably determined whether the possible products
formed will be sufficiently insoluble to escape from
a
poster-
iori
proteolysis of the newly synthesized peptide bonds.
Notwithstanding the above-mentioned objections, the fact
that the lack
of
unique specificity of some proteolytic enzymes
allows for the formation of various kinds of peptide bonds
should not be ignored. However, it implies a further risk. The
inherent capacity of these proteases to act at
a
variety of
peptidic substrates jeopardizes pre-existing, scissile bonds
when dealing with fragment condensation.
If
hydrolysis oc-
curs, the resultant cleavage products may nevertheless act as
substrates and give rise to undesired compounds. Conse-
*
The costs of publication of this article were defrayed in part by
the payment of page charges. This article must therefore be hereby
marked “adc~ertisement” in accordance with
18
U.S.C.
Section 1734
solely to indicate this fact.
quently, these imponderables keep the outcome
of
protease-
catalyzed reactions in suspense, thus making methodical de-
sign of a synthesis more difficult or even rendering it a trial
and error procedure.
Recently, two alternative routes to sequential synthesis of
Leu- and Met-enkephalin were reported
(10).
The peptide
bonds were catalytically formed either by papain or n-chy-
motrypsin. In the progress of this work, several pathways had
to be discontinued because they proved to be dead ends. In
this paper, some unsuccessful strategies for the preparation of
opioid peptides are described. They are depicted in Fig.
1
together with the synthetic routes that do lead to the desired
products.
EXPERIMENTAL PROCEDURES
All chemicals and solvents were reagent grade. Bocl-amino acids
synthesis of Boc-Tyr-OEt
(I)
and Boc-Phe-OEt
(XXI)
followed the
were purchased from Fluka and were of the L-configuration. The
method reported by Yonemitsu et
al.
(11). Boc-Gly-NLH2Ph (II), Boc-
Phe-NZHsPh
(V),
and Boc-Leu-NLHLPh (VIII) were prepared by
papain-catalyzed condensation in the presence of 2-mercaptoethanol,
referring to methods described by Milne and Carpenter (12). Prior to
use, their purity was confirmed by thin laver chromatography and
elementary analysis.
Deacylation of Boc-amino acid or peptide phenylhydrazides was
achieved as reported previously (10).
Boc-Gly-Phe-OH was obtained from Boc-Gly-Phe-NLHLPh (VI)
after removal of the phenylhydrazide group by FeCIl treatment, as
described for the preparation of Boc-Tyr(Bz1)-Gly-OH (IV) (10).
Papain (EC 3.4.22.2) and thermolysin
(EC
3.4.24.4) were obtained
from Sigma and Bohringer, respectively.
Prepacked Silica Gel 60 columns were purchased from Merck
(Darmstadt). Thin layer chromatograms were developed on precoated
silica gel plates (Merck) using the following solvent systems
(v/v):
System A, chloroform/methanol (3:l); System B. chloroform/meth-
anol/acetic acid (45:4:1).
Enzymatic Synthesis
(Fig.
I)
Boc-Gly-Gly-N2H2Ph (XVZZZ)-Boc-Gly-OH (2.28 g, 13 mniol) and
H-Gly-N,HLPh.CF.lCOOH (3.63
g,
13 mmol) were dissolved in 150 ml
of 3
M
sodium acetate buffer (pH 6.25) which was 2.7
M
in potassium
chloride. 2-Mercaptoethanol (1.4 ml) was added following which the
solution was kept at 40°C in the presence of papain
(2
g) for 40 h.
The reaction mixture was extensively extracted with ethyl acetate.
The organic layer was washed in succession with 0.1
N
HCI, water,
59;
aqueous ammonia, water, and dried over NaZSOt. On evaporation, an
oil was obtained which was further purified bv means of HI’LC on a
prepacked Silica Gel 60 column (44
X
3.7 cm). The pure dipeptide
(XVIII)
was eluted from the column using chloroform/methanol (50:
1)
(v/v).
Cr~ystallization from methanol with ether yielded 2.58 g (8.85
mmol, 68%). Chromatographically homogeneous in Systems A and
8;
m.p. 175-177°C.
~~~~~ ~~ ~~~~ ~ ~~~~~~~~~~ ~
.~~
I
The abbreviations used are: Boc, t-butyloxycarbonyl; Bpoc.
2-(4-
biphenyl)-2-propyloxycarbon,~l;
Bz. benzoyl;
Rzl,
benzyl; I’h, phenyl;
OEt, ethyl ester; OTMB,
2,4,fi,-trimethylbenzylester;
HPLC. high
performance liquid chromatography.
1301
This is an Open Access article under the CC BY license.
pf3
pf4

Partial preview of the text

Download Protease-mediated Peptide Bond Formation and more Summaries Biochemistry in PDF only on Docsity!

THE JOURNALOF BIOLOGICAL CHEMISTRY

Printed m U.S.A.

Val. 256, N o. 3, Issue of February 10, pp. 1301-1304, 1981

Protease-mediated PeptideBond Formation

ON SOME UNEXPECTED OUTCOMES DURING ENZYMATIC SYNTHESIS OF LEU-ENKEPHALIN*

(Received for publication, August 6,1980)

Willi Kullmann From the Max-Planck-Znstitut fur Biophysikalische Chemie, 0.3400 Gottingen, Am Fussberg. Federal Republic of Germany

In the course of a study in protease-controlled peptide synthesis, several promising pathways to synthetic en- kephalins had to be discarded or modified because they failed to give the required products. Partial deprotec- tion of peptide fragments prior to chain elongation resulted in anenhanced susceptibility of scissile bonds

to proteolysis. The use of proteases, the specificity of

which was not confined solely to the bond to be synthe-

sized, thus led to a priori cleavage of pre-existing pep-

tide bonds. Subsequently, enzyme-mediated synthesis

of new peptide bonds between initial reactants and

nascent degradation products furnished undesired, of- ten truncated peptides.

A detailed characterization of the undesired products

gave information as to whetber or not the peptide bonds were susceptible to proteolytic cleavage or ac- cessible via enzymatic synthesis. In this way, the un-

expected outcome of protease catalysis led to working

predictions regarding enzyme-mediated peptide bond formation, and thus, finally contributed to the success- ful synthesis of the target peptides.

Peptide bond formation on a preparative scale by the agency of proteases hasbecome a rapidly developingfield (1- 10). In this approach, theenzymatic specificity suppresses the formation of undesired side-products often foundin the course of conventional synthesis. Inparticular,it providesfor an outstanding way of maintaining chiral integritybecause of the stereoselectivity of the proteases. Furthermore, since the products areoften largely insoluble inthe reactionmedia, this method facilitates the purification procedure. Despite these promising features, the enzymatic procedure has not yet reachedgeneral applicability. Much of this draw- back is due to thespecificity, which is often not sharp enough to permit predictions whether and to what extent thedesired compoundsare going to be formed. On theotherhand,it cannot be reliably determined whether the possible products

formed will be sufficiently insoluble to escape from a poster-

iori proteolysis of the newly synthesized peptide bonds. Notwithstanding the above-mentionedobjections, the fact that thelack of unique specificity of some proteolytic enzymes allows for the formation of various kinds of peptide bonds should not be ignored. However, it implies a further risk. The inherent capacity of these proteases to act at a variety of peptidic substrates jeopardizespre-existing, scissile bonds when dealing with fragment condensation. If hydrolysis oc- curs, the resultant cleavage products may nevertheless act as substratesand give rise to undesiredcompounds.Conse-

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “adc~ertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

quently, these imponderables keep the outcome of protease- catalyzed reactions in suspense, thus making methodical de- sign of a synthesis more difficult or even rendering it a trial and error procedure. Recently, two alternative routes to sequential synthesis of Leu- andMet-enkephalin were reported (10). Thepeptide bonds were catalytically formed either by papain or n-chy- motrypsin. In the progress of this work, several pathways had to be discontinued because they proved to be dead ends. In this paper, someunsuccessful strategies for the preparationof opioid peptidesare described. Theyaredepicted in Fig. 1 together with the synthetic routes that dolead to the desired products.

EXPERIMENTALPROCEDURES All chemicals and solvents were reagent grade. Bocl-amino acids

synthesis of Boc-Tyr-OEt (I) and Boc-Phe-OEt (XXI) followed the

werepurchasedfromFlukaandwere of the L-configuration. The

method reported by Yonemitsu et al. (11).Boc-Gly-NLH2Ph (II),Boc- Phe-NZHsPh (V), and Boc-Leu-NLHLPh (VIII)wereprepared by papain-catalyzed condensation in the presenceof 2-mercaptoethanol, referring to methods describedby Milne and Carpenter (12). Prior to use, their purity was confirmed by thin laver chromatography and elementary analysis. Deacylation of Boc-amino acid or peptide phenylhydrazides was achieved as reported previously (10). Boc-Gly-Phe-OHwasobtainedfromBoc-Gly-Phe-NLHLPh(VI) after removal of the phenylhydrazide group by FeCIl treatment, as described for the preparationof Boc-Tyr(Bz1)-Gly-OH (IV) (10). Papain (EC 3.4.22.2) and thermolysin (EC 3.4.24.4) were obtained from Sigma and Bohringer, respectively. PrepackedSilicaGel60columnswerepurchasedfromMerck (Darmstadt). Thin layer chromatograms were developed on precoated silica gel plates (Merck) using the following solvent systems (v/v): System A, chloroform/methanol (3:l); System B. chloroform/meth- anol/acetic acid (45:4:1).

Enzymatic Synthesis (Fig. I)

Boc-Gly-Gly-N2H2Ph(XVZZZ)-Boc-Gly-OH (2.28 g, 13 mniol) and H-Gly-N,HLPh.CF.lCOOH (3.63g, 13 mmol) were dissolvedin 150 ml of 3 M sodium acetate buffer (pH 6.25) which was2.7 M in potassium chloride. 2-Mercaptoethanol (1.4 ml) was added following which the solution was kept a t 40°C in the presence of papain (2 g) for 40 h. T h e reaction mixture was extensively extracted with ethyl acetate. T h e organic layer was washed in succession with0.1 N HCI, water, 59; aqueous ammonia, water, and dried over NaZSOt. On evaporation, an oil was obtained which was further purifiedbv means ofHI’LC on a prepacked Silica Gel 60 column (44 X 3.7 cm). The pure dipeptide (XVIII) was eluted from the columnusing chloroform/methanol (50:

  1. (v/v). Cr~ystallization from methanol withether yielded 2.58 g (8. mmol, 68%). Chromatographically homogeneousin Systems A and 8; m.p. 175-177°C.
I The abbreviations used are: Boc, t-butyloxycarbonyl; Bpoc. 2-(4- **biphenyl)-2-propyloxycarbon,~l;** Bz. benzoyl; **Rzl,** benzyl; I’h, phenyl; OEt,ethylester;OTMB, 2,4,fi,-trimethylbenzylester; HPLC. high performance liquid chromatography. This is an Open Access article under the CC BY license. ## 1302 Side-reactions during Protease-catalyzed Peptide Synthesis ### m,< ; , , i r , , ,,', '.r."-p.. I , ,"Y ## P&PA *. - qor j , , G ,. a. r." .,.. *.. ## - -.,, 0 8 , 1 YC,., ## - -I.; 3,m.v- ,. **_&~-~yrl&!~-~-?+Jf,FMk%'lJ_** FIG. 1. Failing and successful pathways **to** enzymatically ### prepared Leu-enkephalin. Dashed lines indicatetargetedhut missed products. The actual, undesired products are **_shaded._** Cl~~HrZNt0.t Calculated: **_C_** 55.88. H **_6.87._** N **17.** Found: C 56.26, H 7.21, N **17.** ### Roc-Tyr-Gly-[;Iy-N?H,Ph (XIX)-Boc-Tyr-OEt ( I ) (1.24 g. 4 mmol) and H-Cly-Cly-N,H,l'h.CFI COOH (2.69 g, 8 **mmol)** were suspended in 40 **ml** of dimethylformamide. 0.2 **M** carbonate buffer **( 1 2 )** (v/v) (pH 9.9).Afteraddition of145 mg of a-chymotrypsin the reaction pro- ceeded under vigorous stirring at **room** temperature for **10** min and wasthenstopped by acidification topH 2.8 using **1 N** HCI. T h e resultingprecipitatewasremoved by filtrationandsuccessively washed with water, 0.5 **M** NaHCO.,. water, and dried **_in ~ ( t c u o_** over NaOH. Further purification via HPLC as described for Compound XVIII gave the pure tripeptide (XIX) which was recrystallized from hot ethyl acetate. Homogeneous in Systems A and B. Yield: 1.03 **g (2.12** mmol, 53%); **m.p.** 125-128OC. Cz.tH:uNr,O,; Calculated: C 59.37, H 6.43 N 14. Found: C 59.50. H 6.27 N 14. ### Boc-Tyr(Bzl).GIv.CIy-OH(XX)-Boc-Tyr-CIy-Cly-NZHZl'h (XIX) (970 mg. 2 mmol) was treated in succession with FeCI:,.HzO (6.4 g) and benzyl bromide (0.03 **ml,** 2.8 mmol) under conditions identical with those previously described for the preparationof Roc-Tyr **(Bzl)-** Cly-OH ( I V ) **(10)** to give **426 mg** of compound XX **_(0.88_** **mmol,** 44'7). Compound XX was crystallized from methanol/ether and was ho- mogeneous in Systems A and **R;** m.p. **105-106°C** CzsH.,tN:10: Calculated: C 61.85, H 6.43. N 8. Found: C 62.01. H 6.29. N 8. ### Boc-Phe-Leu-NLH2Ph (XXII)-a-Chymotrypsin (30 mg) was added to a suspension of Roc-Phe-OEt (XXI) (293 **mg,** 1 **mmol)** and H-Leu- NzH?I'h.CF., COOH (335 mg. **1 mmol)** in 9 **ml** of dimethylformamide. 0.2 **M** carbonate buffer (1:2) (v/v) (pH **10.1).** T h e reaction proceeded undervigorousstirringfor **10** min at roomtemperatureandwas terminated by acidification to pH 3.0 using **1 N** HCI. T h e precipitate which had been formed was worked upa s depicted for the tripeptide (XIX). A final fractionation step involving HPLC and using chloro- form as eluantprovided the dipeptide (XXII).which was homogene- **ous** in Systems A andB. Recrystallization from ethanol/water yielded **380** mg of Cornpound XXII (0.81 **mmol.** 817); **m.p. 186-188°C.** CzcH.,N,Ot Calculated: C 66.65, H 7.74. N **11.** Found: C 67.15, H 7.69, N 12. ### Boc-Tyr(Bzl)-Cly-Phe-Leu-N~H~Ph(XYIIII)-Boc-Tyr(Bzl)-Gly- **Cly-OH** (XX) (194 mg, 0.4 mmol)andH-Phe-Leu-NIHZPh. CF,COOH (193 **mg.** 0.4 mmol) were dissolved in **6** ml of ethanol/ McIlvainbuffer (2:3) (v/v) (pH **6.0).** 2-Mercaptoethanol **(0.016** ml) was added following which the solution was incubated at **38°C** in the presence of papain (20 mg). After 5 h, the resulting precipitate was collected by filtration. washed successively with5'; citric acid, water. 5% aqueous ammonia, water. and dried **_in lwcuo_** over NaOH. The tetrapeptide (XXIII) was eluted froma prepacked silica gel column with chloroform. lkuvstallization from methanol/ether gave chro- matographicallv homogeneous XXIII (Systems A and B). Yield: **_T2._** mg **(0.29** mmol. **_V i ) ;_** **m. p.** 216-219°C. CIIH;tN+,O: Calculated: C **_67.8:%._** H **6.99.** N **10.** Found: **C** **_68.05._** H **_6.75._** N **10.** Amino acid analysis: **Cly.** 1 **.OO( 1** ); Leu. **0.97** ( **1 ) : Tyr. 0. 9 1** ( **1** ); I'he **1. ( 1 ).** ### Boc.Tvr-N.H?Ph (S.YIV)-2-Mercal)toethanol (0.14 ml) and pa- pain **( 1 0 0 mg)** were added to a solution of Roc-'l'vr-OH (140 **mg.** **_0._** mmol) and H-Cly-N,H~l'h.CFICOOH (279 mg. **1** nlmol) i n 10 nllof methanol, **3 M** acetate buffer (1:5) (v/v) (pH 4.9). After incubation at **38'C** for 50 h, the reaction mixture was worked up as described for CompoundXVIII.Crystallizationfromchloroformgave 30 nlg of CompoundXXIV (0.08 **mmol.**^167 basedonRoc-Tyr-OH).^ **Homo-** geneous in Systems A and €3; m.p. 178-180OC. C,,H,:,N Calculated: C 64.64. H **_6.78,_** N **1 1. 3 6** Found: C **64.32,** H **6.M.** N **11.** Amino acid analysis: **Cly,** negative. **Tyr.** positive. ### Boc-GIwLeu.N?HJ'h (SS~')-Boc-<;ly-I'he-OH (130 mg.0. mmol) and H-Leu-N,H?l'h.CF,COOH ( 134 **mg.** 0.4 **mmol)** were dis- solved in 5 **ml** of ethanol/McIlvain buffer **( 1 2 )** (v/v) (pH **6.1).** T h e solution was reacted with 2-mercaptoethanol **_(0.032_** ml) and papain (40 **mg)** at 38°C for **36** h. The reaction mixture was then repeatedly extracted with ethyl acetate and workedu p as reported ahove for the dipeptide (XVIII). After fractionation via HI'LC, the protected di- peptide(XXV)waselutedwithchloroform/methanoI **(8O:I)** (v/v) following which Boc-Clv-N!H.l'h **(11)** was washed from the column using chloroform/methanol (40:l)(v/v)^ **as**^ eluant. The products were homogeneous in Systems A and **R.** Compound XXV crystallized from ethanol/water to yield **72** mg **(0.19 mmol.** 48';) n1.p. 138-139°C. Ct*+HwNtOa Calculated: C **W.:30.** H 7.111). N 14. Found: C **60.23,** H **7.96.** N 14. Amino acid analysis: **Cly, l.OO(1);** Leu, **0.96(1);** I'he, negative. Boc- Gly-NyH?l'h **i l I )** was crystallized from ethvl acetate with petroleum ether to give **I L 6** mg (0.04 **mmol, 10%).** m.p. 122-124°C. CI ,HI*,N **IO.,** Calculated: C 58.84. H 722. N 15. Found: C 58.71, H **7.1** 1, N **15.** Amino acid analysis: **Gly.** positive; Leu, negative; I'ht., negative. ### Boc-Tyr(Bzl)-Phe-NzH?Ph (XXVI)-Boc-l'yr(Bzl)-Glv-Cly-OH (XX) (145 **mg.** 0.3 mmol) and H-l'he-NZH,I'h.CF,COOH (1 10 **mg, 0.** mmol) were dissolvedin **_6_** ml of methanol/Veronal buffer ( **1 2 )** (v/v) (pH 7.5). After addition of thermolysin (25 mg), the solution waskept a t 38OC for **18** h. T h e resulting precipitate was removed by filtration and worked up as described for Compound XXII. Homogeneous in SystemsAand B. Recrystallizationfromethylacetate/petroleum ether gave 91 mg of XXVI **(0.15 mmol, 5 0 % ).** m.p. 218-220°C. C.W,H.~,N.IO~, Calculated: C **71.03,** H 6.62. N **9.** Found: C 71.06. H 6.37, N 9. Amino acid analysis **Gly.** negative; Tyr. **O.W(1);** Phe. **I.OO(1).** **RESULTS A N D DISCUSSION** ### The fmt design of a protease-catalyzed synthesis of Leu- ### enkephalin implied a finalfragment condensation of Boc- ### Tyr(Bz1)-Gly-Gly-OH( X X ) and H-Phe-Leu-N2HzPhwith pa- **1304** **_Side-reactionsProtease-catalyzedduring Peptide Synthesis_** increased the susceptibility to proteolysis of their scissile bonds. The drive toward hydrolytic action was additionally strengthened by the imminent tendency of partially depro- tected substrates tofurnish energetically favored dipolar ions on peptide bond cleavage. Non-reactivity of these ions proteo- lytically split off prior to enzymatic synthesis led tothe ### truncated peptides characterized above. A different kind of undesired productsresulted fromreutilization of formerly excised free amino acids duringprotease-mediatedpeptide synthesis. The random insertion of surplus amino acids or their enzymatically derived oligomers led to fully protected peptides which exceeded the required chain length. ### This phenomenon was described by Janssen et al. (15) for the papain-aided reaction of Bz-Phe-OH and H-Gly-NH-Ph that, in additiontothe above-mentioned Bz-Phe-NH-Ph, yielded the tripeptide Bz-Phe-Gly-Gly-NH-Ph. In thecourse **of** the present study, an attempt to preparevia papain catal- ysis thetripeptideBoc-Gly-Gly-Phe-N2H2Phstarting with either Boc-Gly-OH and H-Gly-Phe-N,H2Ph or Boc-Gly-Gly- OH and H-Phe-N2H2Ph resultedin the formation of Boc- peptidylphenylhydrazides theamino acid composition of which was determined to be (approximately): Gly(l), Phe(2); andGly(6),Phe(1):andGly(3), Phe(l), Gly(l), Phe(2), re- spectively. These findings suggest proteolyticcleavage of both thepeptidebonds of Boc-Gly-Gly-OH andH-Gly-Phe- N2H2Ph and the partial removalof the phenylhydrazide moi- ety of theaminocomponents followed by papain-induced introduction of avarying number of free amino acids. As proposed by Anderson and Luisi for the oligomerization of amino acids esters by papain (17), the enzymatic reaction may need an initiator like Boc-Gly-OH to begin with. The elonga- tion of the peptide chain then may be terminated by intro- ducing an aminoacyl phenylhydrazide, which probably favors the precipitation of the products. The chain length was not determined and cannot be derived from amino acid analyses, which served solely to reveal the failure to synthesize the desired peptides. It isself-evident that a generally valid method of suppress- ing the undesired properties of the proteases does not exist. However, the synthetic pathways which proved to be dead ends can be by-passed by reasonable detours. This requires the selection of suitable peptide fragments to serve as sub- strates. Thispurpose is facilitated by a detailedinterpretation of the resultsof undesired enzymatic reactions withparticular emphasis on the site where preferential splitting of peptide bonds occurs. By taking into account the fact that the prote- olytic andsynthetic specificities of theproteasesarefre- quently indistinguishable, the enzymes can be beaten at their own game. Furthermore,theendangeredreactants can be rendered more resistant to _a_ **_priori_** proteolysis by increasing their hydrophobicity. Consequently, they are removed more rapidly fromthe solution as integral parts of the newly formed insoluble products. This procedure proved suitable when ap- ### plied to the synthesisof the pentapeptide (XIV). An additional benzyl group enabled the preparation of the desired enkeph- alin derivative in spite of the presence of two peptide bonds susceptible to protease action. Unfortunately, thisprinciple is not generally applicable, as demonstrated both by the failure to obtain the appropriate pentapeptidederivatives using Boc- ### Tyr(Bz1)-Gly-Gly-OH (XX) and varying phenylalanylleucine ### peptides displaying increasingly hydrophobic properties (see ### above) and by the inability of reacting Bpoc-Gly-Phe-OH and H-Leu-OTMB to yield the corresponding tripeptide. In both cases proteolytic cleavage of preexisting peptide bonds pre- vented the synthesis of the required products. Last but not least, modification of synthetic concepts toenable the use of more than one protease with noninterfering specificities can provide for pathways leading to the targetpeptides. In summary, application in peptide synthesis of proteases exhibiting abroad specificity cannot ensure anunambiguously predictableoutcome. To exploit the multifunctional poten- tialities of these enzymes, awareness is needed of the limita- tions. Consequently, a critical evaluation of the nature of the resultant peptidesis indispensable to avoid serious confusions. 1. **2. 3. 4.** **5.** **6.** **7.** **8.** **9.** **10. 11.** **12.** **13.** **14.** **15.** **16.** **17.** **REFERENCES** ### Oka, T., and Morihara, K. (1977) J.Biochem. (Tokyo) 82, 1055- ### Morihara, K., and Oka, T. (1977) Biochem. J. 163, 531- **Pellegrini, A,, and Luisi, P.** L. **(1978)** **_Biopolymers_** **17, 2573- Isowa, Y., and Ichikawa, T. (1978)** **_Bull. Chem. Soc. Jpn._** **52, 796- 800** ### Inouye, S., Watanage, K., Morihara, K., Tochino,Y., Kanaya, T., **Emura, J., and Sakakibara,** _S._ **(1979)** _J._ **_Am. Chem._** _Soc._ **101, 751- Kullmann, W. (1979)** **_Biochem. Biophys. Res. Comrnun._** **91, 693- 698 Homandberg,** _G._ **A,, and Laskowski, M., Jr. (1979)** **_Biochemistry_** **18, 586- Kuhl,** P., **Konnecke, A,, Doring, G., Daumer,** H., **and Jakubke, H.-D. (1980)** **_Tetrahedron Lett._** **21,893- Morihara, K., Oka, T., Tsuzuki,** H., **Tochino, Y., and Kanaya, T. (1980)** **_Biochem. Biophys. Res. Commun._** **92,396-** ### Kullmann, W. (1980) J.Biol. Chern. 255,8234- **Yonemitsu,** O., **Hamada, T., and Kanaoka, Y. (1969)** **_Tetrahedron_** **Milne, H. B., and Carpenter,** F. H. **(1968)** _J._ **_Org. Chem._** **33,4476-** **Milne,** H. **B., and Most,** **_C._** F., **Jr. (1968)** _J._ **_Org. Chem._** **33, 169-** **Schechter, I., and Berger, A. (1968)** **_Biochem. Biophys. Res._** ### Janssen, F., Winitz, M., and Fox, S. W. (1953) J.Am. Chem. Soc. **Morihara, K., and Tsuzuki, H. (1970)** **_Eur._** _J._ **_Biochem._** **15, 374-** **Anderson,** _G.,_ **and Luisi,** P. L. **(1979)** **_Helu. Chim. Acta_** **62, 488-** **1062** **_Lett._** **23, 1819-** **4479** **175** **_Commun._** **32,898-** **75,704-** **380** **494**